Berlin – September 09, 2026 -- The TÜV Association has warned that the AfD's strong showing in the Saxony-Anhalt state election threatens Germany's evidence-based approach to climate, energy and digital policy.

Raamsdonksveer, Netherlands – September 09, 2026 -- Dutch company PAL-V has obtained European Production Organisation Approval (POA), becoming the first company in the FlyDrive segment of Advanced Air Mobility to hold both automotive and aviation production approvals for industrial-scale manufacturing.

Frankfurt am Main – September 09, 2026 -- Thirty percent of German small and mid-sized companies (Mittelstand) with foreign business expect their cross-border revenues to decline over the next three years, according to a new KfW Research study, with 6 percent forecasting a sharp drop. Roughly 24 percent anticipate growth, while 47 percent expect no change.

The findings stem from a January 2026 survey conducted before the outbreak of the Iran conflict, meaning sentiment may have since deteriorated further.

Beijing/Florence – September 08, 2026 -- Gan & Lee Pharmaceuticals (603087.SH) has signed an exclusive licensing agreement with Italy's The Menarini Group for its GLP-1 receptor agonist bofanglutide, a deal worth up to €726 million excluding royalties.

Beijing/Florence – September 08, 2026 -- Gan & Lee Pharmaceuticals (603087.SH) has signed an exclusive license agreement with Italy's Menarini Group worth up to €726 million, excluding royalties, to develop and commercialize the obesity drug bofanglutida across 39 European markets.

Beijing – September 08, 2026 -- Gan & Lee Pharmaceuticals (603087.SH) has signed an exclusive license agreement with Italy's Menarini Group worth up to EUR 726 million, excluding royalties, to register and commercialize its GLP-1 receptor agonist bofanglutide for obesity and overweight treatment across 39 countries.

Berlin – September 07, 2026 -- Germany's largest pharmaceutical trade association, Pharma Deutschland, has warned that new cost-containment measures under the GKV-BStabG threaten drug supply, innovation, and investment in the country, even as it welcomes a fresh round of government dialogue on AMNOG reform.

Hong Kong – September 07, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics and secure distribution rights for the SentireTM surgical robotic system across select ex-US markets where it has regulatory approval.

Hong Kong – September 7, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics as part of a strategic partnership granting the medical device giant distribution rights to the SentireTM surgical robot in markets outside the United States where the system holds regulatory clearance.

Hong Kong – September 07, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics as part of a strategic partnership granting the medtech giant distribution rights to Cornerstone's Sentire surgical robot in select markets outside the United States.